News and Trends 10 Nov 2022
Ascentage Pharma gets Chinese approval for solid tumor study
Ascentage Pharma says its novel inhibitor of the embryonic ectoderm development (EED) protein, APG-5918, has been approved by the Center for Drug Evaluations (CDE) of China National Medical Products Administration…